Armina Fortuna Riethmuller

Armina Fortuna Riethmuller is an experienced professional in drug safety and pharmacovigilance with a strong background in compliance and operational management across multiple pharmaceutical companies. Currently, Armina serves as the Director of Drug Safety Operations and Compliance Europe, along with the role of Deputy EU QPPV at Cytokinetics since September 2025. Prior experience includes serving as Senior Director, EU QPPV at Idorsia Pharmaceuticals Ltd, and Director positions in pharmacovigilance at The Janssen Pharmaceutical Companies and Actelion. With a Master of Science in Pharmacovigilance from the University of Hertfordshire and extensive auditing and compliance experience, Armina has demonstrated expertise in ensuring drug safety regulations, overseeing safety profiles, and managing complex pharmacovigilance systems. Armina's early career included nursing roles, further emphasizing a commitment to patient care.